Literature DB >> 1774159

Myocardial ischemia related to ergot alkaloids: a case report and literature review.

B S Galer1, R B Lipton, S Solomon, L C Newman, E L Spierings.   

Abstract

Ergotamine tartrate and methysergide are widely used headache treatments with important vasoconstrictive properties. We report a 31-year-old man with cluster headaches who developed severe, prolonged myocardial ischemia following combination therapy with ergotamine tartrate and methysergide. We reviewed the cardiovascular complications of each agent alone and in combination. Given the pharmacologic similarity of these agents, we propose that they may have additive or synergistic cardiac toxicity, at least in vulnerable individuals. We recommend caution when these agents are used together.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1774159     DOI: 10.1111/j.1526-4610.1991.hed3107446.x

Source DB:  PubMed          Journal:  Headache        ISSN: 0017-8748            Impact factor:   5.887


  4 in total

1.  The effect of rizatriptan, ergotamine, and their combination on human peripheral arteries: a double-blind, placebo-controlled, crossover study in normal subjects.

Authors:  Peer Tfelt-Hansen; Kaj Seidelin; Michael Stepanavage; Christopher Lines
Journal:  Br J Clin Pharmacol       Date:  2002-07       Impact factor: 4.335

Review 2.  Migraine Treatment: Current Acute Medications and Their Potential Mechanisms of Action.

Authors:  Jonathan Jia Yuan Ong; Milena De Felice
Journal:  Neurotherapeutics       Date:  2018-04       Impact factor: 7.620

3.  An unusual cause of chest pain: Acute coronary syndrome following administration of ergotamine tartrate.

Authors:  Sercan Okutucu; Ugur Nadir Karakulak; Giray Kabakcı; Kudret Aytemir
Journal:  Exp Clin Cardiol       Date:  2012

Review 4.  Ergotamine and dihydroergotamine: a review.

Authors:  Marcelo E Bigal; Stewart J Tepper
Journal:  Curr Pain Headache Rep       Date:  2003-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.